Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TYRO3 and EPHA2 Expression Are Dysregulated in Breast Cancer. | Cell Biochem Funct | 2024 | 39327735 | PubTator, text mining | PubMed |
| MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity. | Leukemia | 2024 | 39322710 | PubTator, text mining | PubMed |
| The protective role of Mertk in JEV-induced encephalitis by maintaining the integrity of blood-brain barrier. | Virol J | 2024 | 39277738 | PubTator, text mining | PubMed |
| SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer. | Cancer Immunol Immunother | 2024 | 39235596 | PubTator, text mining | PubMed |
| E3 ubiquitin ligase BTBD3 inhibits tumorigenesis of colorectal cancer by regulating the TYRO3/Wnt/β-catenin signaling axis. | Cancer Cell Int | 2024 | 39227913 | PubTator, text mining | PubMed |
| Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours. | Oncogene | 2024 | 39179860 | PubTator, text mining | PubMed |
| Hallmarks of pancreatic cancer: spotlight on TAM receptors. | EBioMedicine | 2024 | 39137571 | PubTator, text mining | PubMed |
| MERTK Inhibition as a Targeted Novel Cancer Therapy. | Int J Mol Sci | 2024 | 39062902 | PubTator, text mining | PubMed |
| Could Gas6/TAM Axis Provide Valuable Insights into the Pathogenesis of Systemic Sclerosis? | Curr Issues Mol Biol | 2024 | 39057085 | PubTator, text mining | PubMed |
| GAS6 and AXL Promote Insulin Resistance by Rewiring Insulin Signaling and Increasing Insulin Receptor Trafficking to Endosomes. | Diabetes | 2024 | 39046834 | PubTator, text mining | PubMed |
| Elevated Plasma Levels of Growth Arrest Specific 6 (Gas6) Protein in Severe Obesity: Implications for Adipose Tissue and Inflammation. | Med Sci Monit | 2024 | 38932442 | PubTator, text mining | PubMed |
| Gas6 and Protein S Ligands Cooperate to Regulate MerTK Rhythmic Activity Required for Circadian Retinal Phagocytosis. | Int J Mol Sci | 2024 | 38928335 | PubTator, text mining | PubMed |
| Targeting Tyro3, Axl, and MerTK Receptor Tyrosine Kinases Significantly Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibition. | Cancers (Basel) | 2024 | 38927958 | PubTator, text mining | PubMed |
| Co-targeting JAK1/STAT6/GAS6/TAM signaling improves chemotherapy efficacy in Ewing sarcoma. | Nat Commun | 2024 | 38906855 | PubTator, text mining | PubMed |
| Gas6/TAM system as potential biomarker for multiple sclerosis prognosis. | Front Immunol | 2024 | 38745659 | PubTator, text mining | PubMed |
| Editorial: The therapeutic inhibition of macrophage checkpoints. | Front Immunol | 2024 | 38736871 | PubTator, text mining | PubMed |
| Gas6/AXL Alleviates Hepatic Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the PI3K/AKT Pathway. | Transplantation | 2024 | 38725107 | PubTator, text mining | PubMed |
| Immunological role of Gas6/TAM signaling in hemostasis and thrombosis. | Thromb Res | 2024 | 38723521 | PubTator, text mining | PubMed |
| De Novo Multi-Omics Pathway Analysis Designed for Prior Data Independent Inference of Cell Signaling Pathways. | Mol Cell Proteomics | 2024 | 38703893 | PubTator, text mining | PubMed |
| The Vitamin K-Dependent Anticoagulant Factor, Protein S, Regulates Vascular Permeability. | Curr Issues Mol Biol | 2024 | 38666935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=8